Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway
Young Yun Jung, Jeong‐Hyeon Ko, Jae‐Young Um, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 7, pp. 5253-5264
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 126
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 111
Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance
Sophie Vasseur, Fabienne Guillaumond
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential
Chang‐Feng Deng, Neng Zhu, Tanjun Zhao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 72
Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response
Milad Ashrafizadeh, Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1263-1321
Closed Access | Times Cited: 62
Lipid metabolism in pancreatic cancer: emerging roles and potential targets
Xinpeng Yin, Ruiyuan Xu, Jianlu Song, et al.
Cancer Communications (2022) Vol. 42, Iss. 12, pp. 1234-1256
Open Access | Times Cited: 64
Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review
Rexiati Ruze, Jianlu Song, Xinpeng Yin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
Si Fang, James Yarmolinsky, Dipender Gill, et al.
PLoS Medicine (2023) Vol. 20, Iss. 1, pp. e1003988-e1003988
Open Access | Times Cited: 33
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114168-114168
Open Access | Times Cited: 28
Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer
Jie Ren, Bo Ren, Xiaohong Liu, et al.
Cancer Letters (2024) Vol. 587, pp. 216649-216649
Closed Access | Times Cited: 13
The Causal Relationship between PCSK9 Inhibitors and Malignant Tumors: A Mendelian Randomization Study Based on Drug Targeting
Wenxin Wang, Wei Li, Dan Zhang, et al.
Genes (2024) Vol. 15, Iss. 1, pp. 132-132
Open Access | Times Cited: 11
Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment
Yanyan Zhang, Zhichao Yang, Yuchen Liu, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
Sepideh Mirzaei, Mohammad Gholami, Hui Li Ang, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3348-3348
Open Access | Times Cited: 44
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover
Nikki L. Raftopulos, Tinashe C. Washaya, Andreas Niederprüm, et al.
Cancer & Metabolism (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 33
Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects
Mehrdad Hashemi, Sepideh Mirzaei, Maryamsadat Barati, et al.
Life Sciences (2022) Vol. 309, pp. 120984-120984
Closed Access | Times Cited: 29
Acetyl-CoA metabolism as a therapeutic target for cancer
Guo Chen, Banghe Bao, Cheng Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115741-115741
Open Access | Times Cited: 22
Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics
Aviral Kumar, Sosmitha Girisa, Mohammed S. Alqahtani, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 810-810
Open Access | Times Cited: 20
Role of STAT3 in pancreatic cancer
Zachary Hamel, S. Calabrese Sánchez, David Standing, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 1, pp. 20-33
Open Access | Times Cited: 8
Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 7
Kaempferide triggers apoptosis and paraptosis in pancreatic tumor cells by modulating the ROS production, SHP‐1 expression, and the STAT3 pathway
Young Yun Jung, Ninh The Son, Chakrabhavi Dhananjaya Mohan, et al.
IUBMB Life (2024) Vol. 76, Iss. 9, pp. 745-759
Closed Access | Times Cited: 7
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 34
RAF1 contributes to cell proliferation and STAT3 activation in colorectal cancer independently of microsatellite and KRAS status
Coralie Dorard, Claire Madry, Olivier Buhard, et al.
Oncogene (2023) Vol. 42, Iss. 20, pp. 1649-1660
Open Access | Times Cited: 15
Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms
Yuyuan Zhang, Yongjiang Li, Chun-Dong Xue, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
Yutong Zhao, C.M. Qin, Lin Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189183-189183
Closed Access | Times Cited: 5
An updated review on the potential antineoplastic actions of oleuropein
Yudong Zheng, Zhenzhen Liu, Xiulan Yang, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 365-379
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top